ARTICLE AD BOX
Under marque names similar Wegovy and Ozempic, semaglutide assists value loss and manages diabetes done a bid of regular injections.
Unfortunately, the tiny sting that's required with each dose tin dissuade galore from considering the medicine arsenic an option. A caller clinical trial suggests a pill signifier could soon beryllium a viable alternative.
Semaglutide is presently administered through a play dose of up to 2.4 milligrams injected into the furniture of abdominous implicit the stomach, thigh, oregon the backmost of the precocious arm. Taking a cause successful a pill signifier means little of the cause gets into your strategy compared with an injection (the subcutaneous method).
Related: A Type of Fiber May Have Weight Loss Benefits Similar to Ozempic
An planetary squad of researchers investigated the effects of taking 25 mg of semaglutide regular successful tablet signifier to spot if it could enactment arsenic good arsenic injections.
"The reasons patients whitethorn similar oral medication implicit the subcutaneous way are astir often needle aversion and section tegument reactions," write the researchers successful their published paper.
"In addition, dissimilar injectable agents, oral agents whitethorn not necessitate a refrigerated concatenation of transportation and could widen the scope of obesity attraction successful galore regions of the satellite wherever a deficiency of refrigeration represents a obstruction to access."
Oral semaglutide led to important value nonaccomplishment successful participants. (Wharton et al., N. Engl. J. Med., 2025)The proceedings progressive 205 radical being fixed semaglutide and 102 radical a placebo, alongside fare and workout counseling for 71 weeks. All of the participants, crossed 4 countries, were classed arsenic being overweight astatine the commencement of the trial.
By the extremity of the study, the mean value nonaccomplishment successful the semaglutide radical was importantly higher. The researchers besides noticed improvements successful carnal relation and metabolic wellness markers (such arsenic blood sugar and cholesterol) successful this group.
"In our trial, oral semaglutide astatine a dose of 25 mg erstwhile regular led to a clinically applicable mean simplification successful assemblage value of 13.6 percent (11.4 percent points much than that with placebo), with value nonaccomplishment akin crossed baseline BMI subgroups," write the researchers. "
"Almost a 3rd of the participants successful the oral semaglutide radical had a simplification successful assemblage value of 20 percent oregon more."
The doses of semaglutide were accompanied by broadside effects, mostly involving gastrointestinal problems and nausea, though they were described arsenic "generally non-serious, mild to mean successful severity, and transient". In the semaglutide group, these were experienced by 74 percent of participants, compared with 42.2 percent successful the placebo group.
The findings backmost up an earlier trial that recovered semaglutide taken orally to beryllium effectual for value loss. In that trial, however, the play dose was 50 mg, with benefits lone somewhat amended than those seen here. In different words, 25 mg mightiness beryllium the saccharine spot.
It is important to support successful caput that portion this cause is effectual successful aiding value loss, the weight tin return erstwhile it's stopped, unless different treatments, specified arsenic exercise, are implemented. There are besides much terrible broadside effects for some, and the impacts of semipermanent usage are not yet afloat understood.
Novo Nordisk is the institution down the trial, and the developer of Ozempic. It's presently seeking regulatory approval to contented Ozempic successful packs of tablets. If that support is given, it shouldn't beryllium excessively agelong earlier the cause is made available.
"Our information supports oral semaglutide astatine a dose of 25 mg arsenic an efficacious attraction enactment for obesity," write the researchers.
The probe has been published successful the New England Journal of Medicine.
